Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 22 May 2024 | 13 May 2024 |
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 inter alia to consider and approve 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2024. 2. Recommendation of final dividend if any on the equity shares of the Company for the financial year ended March 31 2024 for approval of the shareholders at the ensuing Annual General Meeting. Recommended Final Dividend of Rs. 5 per share Outcome of Board meeting (As Per BSE Announcement Dated on 22.05.2024) | ||
Board Meeting | 31 Jan 2024 | 15 Jan 2024 |
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve This is to inform that the meeting of the Board of Directors of Sun Pharmaceutical Industries Limited is scheduled to be held on Wednesday January 31 2024 inter alia 1. To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2023 2. To consider and approve declaration of Interim Dividend for the financial year 2023-24 February 9, 2024, is fixed as Record Date for Interim Dividend for FY 2023-24. An interim dividend of Rs. 8.5/- per equity shares of Rs. 1/- each of the company for the FY 2023-24 is declared. Unaudited Financial Results for the quarter and nine months ended December 31, 2023 (As Per BSE Announcement Dated on 31.01.2024) | ||
Board Meeting | 1 Nov 2023 | 13 Oct 2023 |
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2023. Outcome of the Board meeting The Board has approved a Composite Scheme of Arrangement. Detail are provided in the letter attached. (As Per BSE Announcement Dated on 01/11/2023) | ||
Board Meeting | 3 Aug 2023 | 11 Jul 2023 |
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2023 inter alia to consider and approve Unaudited Standalone and Consolidated financial results of the company. As per the letter attached. (As Per BSE Announcement dated on 03.08.2023) |
The warning letter detailed substantial violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals at the facility.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.